DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity

Satoshi Yamashita1, Akira Mori, En Kimura

  • 1Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan. y-stsh@kumamoto-u.ac.jp

Insights

DJ-1 protein levels increase in motor neurons of mice with mutant SOD1, suggesting a role in familial and sporadic ALS. DJ-1 may offer a therapeutic target for motor neuron degeneration.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mutations in the Cu/Zn superoxide dismutase (SOD1) gene are a cause of familial amyotrophic lateral sclerosis (ALS).
  • Misfolded SOD1 protein, oxidative stress, and mitochondrial dysfunction contribute to ALS pathogenesis.
  • DJ-1 (PARK7) is involved in antioxidative responses and linked to familial Parkinson's disease.

Purpose of the Study:

  • To investigate the role of DJ-1 in mutant SOD1-mediated neurotoxicity in ALS.
  • To determine if DJ-1 levels are altered in sporadic ALS patients.

Main Methods:

  • Assessed DJ-1 protein levels in motor neurons of mutant SOD1 transgenic mice.
  • Examined DJ-1 and mutant SOD1 interactions biochemically.
  • Investigated the effects of DJ-1 overexpression on neuronal cell viability and toxicity.
  • Measured DJ-1 levels in cerebrospinal fluid (CSF) from sporadic ALS patients and controls.

Main Results:

  • DJ-1 protein levels were upregulated in motor neurons of mutant SOD1 mice throughout their lifespan.
  • DJ-1 formed complexes with mutant SOD1 in cell lysates.
  • Overexpression of DJ-1 enhanced cell viability and reduced toxicity in mutant SOD1-transfected cells by improving the apoptotic pathway and decreasing oxidative stress.
  • CSF DJ-1 levels were significantly higher in sporadic ALS patients compared to controls.

Conclusions:

  • DJ-1 is upregulated in the context of mutant SOD1 toxicity and may play a role in both familial and sporadic ALS pathogenesis.
  • DJ-1's protective effects against mutant SOD1-mediated toxicity suggest it as a potential therapeutic target for ALS treatment.
  • Further research into DJ-1's mechanisms could lead to advancements in treating motor neuron degeneration.